Share Name Share Symbol Market Type Share ISIN Share Description
Ekf Diagnostics LSE:EKF London Ordinary Share GB0031509804 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00p -4.08% 23.50p 23.00p 23.50p 24.00p 23.25p 24.00p 389,990 13:39:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 38.6 -1.0 0.0 - 109.10

Ekf Diagnostics Share Discussion Threads

Showing 1401 to 1423 of 1425 messages
Chat Pages: 57  56  55  54  53  52  51  50  49  48  47  46  Older
DateSubjectAuthorDiscuss
09/8/2017
19:08
charts still indicate more upside
sirshagalot
07/8/2017
11:35
zwanzigger reduced his holdings
9degrees
18/7/2017
12:34
Kestelmill - I agree re the acquisition de-focus. However, just to qualify that - the only failed acquisition (out of 8) was Selah. This failed because the management team was not experienced enough (and arguably the industry was not ready) to move into molecular diagnostics alongside traditional point of care diagnostics.
tawnyport
18/7/2017
12:29
I would hardly classify a new NED as a new team. Anyway, the crux here is that a new non-exec Chairman is in place and he is an experienced, focussed, and successful individual - he is the one who has given the company a new lease of life by concentrating on an exit-based trade sale strategy, one which the previous Chairman arguably was unable to consummate.
tawnyport
18/7/2017
12:15
So we have more than just one new team member, arguably a different team, and perhaps most importantly, a new focus.
wan
18/7/2017
11:56
Wan - Julian Baines has been there as CEO since the Company listed in 2010; Richard Evans has been COO/CFO (and previously just CFO) since 2011. Adam has been an NED since 2010 and Carl was appointed an NED earlier this year.
tawnyport
18/7/2017
11:36
Tawnyport...I suggest you check the RNS announcements then, along with the following EKF investor page - hxxps://www.ekfdiagnostics.com/investors-directors-advisors.html
wan
18/7/2017
11:17
Wan - the only new management team member is Chris Mills; he replaced David Evans (who was succeeded by Ron Zwanziger for a short period).
tawnyport
17/7/2017
16:25
Large volume today!
wan
06/7/2017
17:04
Kestlemill...No it's not the same management team you refer to. EKF have a new management team in place, it has been restructured, refocused and refinanced, hence the significant improvements that are now flowing through.
wan
06/7/2017
16:48
Don't want to rain on your parade Wan - things are on the up - but isn't this the same management team who bought Selah Genomics for USD 35.6M plus milestone payments then less than two years later gave it back to Selah for nothing and wrote down GBP 41M off EKF's balance sheet?
kestelmill
06/7/2017
15:55
It has taken a long time but finally things are moving in the right direction. Well done. Let's just hope that the cash being generated doen't burn a hole in the management's pockets so that are tempted to make another disastrous (American) acquisition.
interstellar
06/7/2017
09:13
It is likely that the investments in consumable capacity expansion in Germany and replacement of equipment in the US (mentioned in 2016), are starting to be felt. One assumes then that these investments, apart from targeting possible costs savings/increased margins, were in light of increased orders and will also support tenders for new contracts. I note that in 2016 EKF had a particularly strong 3rd quarter (July - Sept), so hopefully the momentum currently being experienced continues and obviously even better if it accelerates!
wan
08/6/2017
17:57
odd 1 million shares just slipped through LATE TRADE AT 21.5P
9degrees
11/5/2017
11:27
Having just read EKF's AR, some ingredients look set to further improve the financials in 2017. This has now been borne out by the most recent trading update for the first quarter where it was good to see that the Board remain optimistic about the Company's prospects for the full year. The impressive and growing installed base of POC instruments provides for an excellent recurring revenue model(razor/razor-blade model). Given the stable and predictable revenues from such a business model, and given plans to spin-off the Lab Diagnostics business (which will create value) along with a potential share buy back, does this imply that EKF might be looking at becoming a high paying dividend stock in the not too distant future? Or will the pure focus on POC diagnostics put EKF back in play as a take-over target (at a much higher premium than previous bids)? Either way, the future appears to look very promising!
wan
02/5/2017
12:45
And linked to previous CFD announcement presumably
intrinsicinvestor
02/5/2017
12:28
Interesting 8m+ deal today at 21.5..
intrinsicinvestor
20/4/2017
16:27
Lots of buys today; anyone speculate?
oilplays
24/3/2017
11:33
Hi All, I'm out of this one. Never thought a year ago I would be able to get out at north of 21p so absolutely delighted. Somehow made £3.5K on this share but on the whole it's not been an enjoyable journey and I have learned a lesson or two. So long and good luck! KM
kestelmill
20/3/2017
08:35
Square1...it will be interesting to see what the US open makes of the news (as I believe eyes from over there must be watching, especially given EKF's installed base of instruments). Depending on how long things take and of course if it happens, in a low interest environment and in percentage terms, today's price and the buy back price offers of a potentially reasonable yield of circa 12%, especially so if things happen in quick fashion!
wan
20/3/2017
08:17
wan- they have clearly put themselves up for sale with offers above 21.5p IMO
square1
20/3/2017
07:50
I appreciate the directors currently hold a strong hand, but could today's news (and much improved Results) also provide the potential for a bid to emerge that values the company more in line with the value inflection and opportunity as that envisaged by splitting the company?
wan
20/3/2017
07:23
LOoks like end game . Company will leave AIM - expect PLUS market at best. AT least you can now get out at 21.5p. If I held I'd take that and not look back
silverfern
Chat Pages: 57  56  55  54  53  52  51  50  49  48  47  46  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V: D:20170822 18:22:50